Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect and safety of fluoxetine initiated in the acute phase of stroke
2011-006130-16Phase 3Active
- Sponsor
- Karolinska Institutet
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stroke comparing Fluoxetine 20 mg once daily with Placebo (2 arms). Primary endpoint: Modified Rankin Scale. Started Jun 2014; status: active.
02
Drugs
fluoxetine
03
Conditions
stroke
Beyond the preview
Go deeper on 2011-006130-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006130-16.